Live Analyst Rating Changes 1653 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kyle Mikson CFA
CG
Kyle Mikson CFA
Canaccord Genuity
Wall Street Analyst
★★☆☆☆
#2195
on 13Foresight · ranked by our own returns
44%
Success Rate
-8.1%
Average Return
11 of 25 calls profitable · -11.2% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 44% of Kyle Mikson CFA's ratings turned a profit when each position was held for 1 year — averaging -8.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

132 Buy 56 Hold 0 Sell
Kyle's Stock Coverage 26 ratings · 2026-06-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
BDSX
Biodesix
 Jun 18, 2026 BUY Strong Buy
+92.4% avg upside
8 analysts
$27.00
60.71% Upside
 ·
ONT
Onterris
 Jun 18, 2026 BUY Strong Buy
+252.3% avg upside
10 analysts
$264.47
1438.49% Upside
 ·
GB:ONT
Oxford Nanopore Technologies PLC
 Jun 17, 2026 BUY Strong Buy
+78.5% avg upside
6 analysts
$200.00
74.10% Upside
 ·
TWST
Twist Bioscience
 Jun 15, 2026 BUY Strong Buy
-26.4% avg upside
14 analysts
$90.00
2.79% Upside
 +8.4%
TXG
10x Genomics
 Jun 10, 2026 BUY Buy
-27.9% avg upside
18 analysts
$32.00
7.86% Downside
 +9.1%
VCYT
Veracyte
 Jun 02, 2026 HOLD Strong Buy
-20.8% avg upside
17 analysts
$42.00
21.59% Downside
 ·
TEM
Tempus AI, Inc. Class A
 Jun 02, 2026 BUY Strong Buy
+33.4% avg upside
19 analysts
$80.00
57.45% Upside
 +1.9%
GRAL
GRAIL Inc
 Jun 01, 2026 BUY Buy
+2.9% avg upside
8 analysts
$80.00
25.57% Upside
 -9.5%
GH
Guardant Health
 May 28, 2026 BUY Strong Buy
-5.9% avg upside
30 analysts
$135.00
2.49% Upside
 -3.1%
QTRX
Quanterix
 May 27, 2026 HOLD Buy
+460.5% avg upside
8 analysts
$4.00
18.03% Upside
 ·
LUCD
Lucid Diagnostics
 May 15, 2026 BUY Strong Buy
+345.6% avg upside
8 analysts
$3.00
177.78% Upside
 +3.4%
SEER
Seer
 May 14, 2026 BUY Strong Buy
+551.3% avg upside
5 analysts
$4.00
129.87% Upside
 -1.7%
XGN
Exagen
 May 11, 2026 BUY Strong Buy
+159.4% avg upside
10 analysts
$8.00
76.18% Upside
 -8.5%
NTRA
Natera
 May 08, 2026 BUY Strong Buy
+7.4% avg upside
26 analysts
$285.00
23.07% Upside
 +16.6%
CAI
Caris Life Sciences, Inc.
 May 08, 2026 HOLD Buy
+54.5% avg upside
20 analysts
$22.00
19.03% Upside
 +2.1%
QSI
Quantum-Si
 May 08, 2026 HOLD Strong Buy
+150.2% avg upside
3 analysts
$1.00
0.14% Upside
 +3.3%
PACB
Pacific Biosciences
 May 08, 2026 BUY Buy
+213.7% avg upside
14 analysts
$3.00
114.38% Upside
 -20.6%
RGEN
Repligen
 May 06, 2026 HOLD Strong Buy
+28.4% avg upside
25 analysts
$145.00
9.88% Upside
 +5.0%
CSTL
Castle Biosciences
 May 06, 2026 BUY Strong Buy
+96.3% avg upside
9 analysts
$40.00
89.44% Upside
 -22.7%
WGS
GeneDx Holdings
 May 05, 2026 BUY Strong Buy
+35.8% avg upside
9 analysts
$75.00
27.06% Upside
 +77.7%
ILMN
Illumina
 May 01, 2026 HOLD Buy
-10.2% avg upside
30 analysts
$140.00
13.56% Downside
 +19.3%
TTOO
T2 Biosystems
 Jul 29, 2024 HOLD Buy
+1421150.0% avg upside
10 analysts
$5.00
999900.08% Upside
 ·
BWAY
Brainsway
 Jun 01, 2021 BUY Buy
-11.7% avg upside
9 analysts
$15.00
0.72% Upside
 -38.8%
PAVM
PAVmed
 Mar 29, 2021 BUY Strong Buy
+725.6% avg upside
5 analysts
$8.00
54.96% Upside
 -59.0%
VNRX
VolitionRX
 Mar 09, 2021 BUY Strong Buy
+590.6% avg upside
11 analysts
$8.00
459.52% Upside
 -31.9%
AWHL
Aspira Women's Health
 Jan 28, 2021 BUY Strong Buy
+1002.0% avg upside
6 analysts
$10.00
1940.90% Upside
 -86.1%
🔒 21 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Kyle Mikson CFA — Frequently Asked Questions
How accurate are Kyle Mikson CFA's stock ratings?
Based on the calls 13Foresight could measure, about 44% of Kyle's ratings were profitable over a one-year hold, with an average return of -8.1% per rating, or -11.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Kyle ranked on 13Foresight?
Kyle Mikson CFA is currently ranked #2195 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kyle cover?
Kyle most recently has ratings on BDSX, ONT, GB:ONT, TWST, TXG, VCYT, TEM, GRAL, GH, QTRX, LUCD, SEER and 14 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.